BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Week in Review: Boehringer Ingelheim Corporation to Build Biopharma CMO in Shanghai


6/10/2013 9:16:34 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

June 8, 2013 -- Boehringer Ingelheim will build a cGMP CMO facility in Shanghai’s Zhangjiang Hi-Tech Park in cooperation with Zhangjiang Biotech and Pharmaceutical Base Development Co. and funded with an $81 million joint investment; the China Securities Regulatory Commission terminated the IPO applications of fifteen China life science companies; Janssen Pharma and the National Taiwan University Hospital will co-develop new drugs for hepatitis B; Genor Biopharma of Shanghai has agreed with BioCND, a Korean biosimilar CRO, to co-develop biosimilars of Humira and Herceptin; China’s Center for Disease Control and Prevention will team up with The Center for Infection and Immunity (CII) of Columbia University to form a Pathogen Discovery lab, housed in China’s CDCP; AngioLight, a cardiovascular medical device company located in Massachusetts, completed a successful initial animal study of its AngioLight™ System at Fu Wai Hospital in Beijing; and more than 750 forward-thinking industry executives converged upon Beijing last week for the ChinaBio® Partnering Forum, China’s premier life science partnering event. More details....

Help employers find you! Check out all the jobs and post your resume.


Read at ChinaBio Today

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES